Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
J Am Soc Nephrol
    October 2026
  1. LIU J, Jin L, Luo F, Zhou S, et al
    Comparative Cardiovascular Outcomes of Lanthanum Carbonate and Sevelamer in Dialysis.
    J Am Soc Nephrol. 2026 Oct 6. doi: 10.1681/ASN.0000001289.
    >> Share

    September 2026
  2. LEE SA, Aulakh G, Chandraker A
    Microplastics and Nanoplastics in Dialysis Patients: An Emerging Safety Question in a Vulnerable Population.
    J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001288.
    >> Share

  3. NISSENSON AR, Hegbrant J, Maddux FW, Strippoli GFM, et al
    Hemodialysis Care: Evolving to Enhance Patient-Level Outcomes.
    J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001286.
    >> Share

  4. BLANKESTIJN PJ, Roos S, Barth C, Bots ML, et al
    Hemodiafiltration: Clinical Practice of Today and a Look into the Future.
    J Am Soc Nephrol. 2026 Sep 22. doi: 10.1681/ASN.0000001282.
    >> Share

  5. FENG Y, Yiu WH, Lam DK, Ma J, et al
    Translocator Protein and Mitochondrial Dysfunction in Chronic Kidney Disease?.
    J Am Soc Nephrol. 2026 Sep 21. doi: 10.1681/ASN.0000001262.
    >> Share

  6. MOLONEY BM, Mc Causland FR
    beta-Blockers in Hemodialysis: Does Dialyzability Matter?
    J Am Soc Nephrol. 2026 Sep 17. doi: 10.1681/ASN.0000001253.
    >> Share

  7. LE D, Ahearn L, Wilk AS, Udani S, et al
    Assessment of Medicare Advantage Stars Measures: Impact on Kidney Care Quality and Future Opportunities.
    J Am Soc Nephrol. 2026;37:2065-2073.
    >> Share

  8. MOLNAR AO, Kang Y, Nash DM, Li L, et al
    Effect of a Change in the Eligibility Criteria for Multidisciplinary Kidney Care.
    J Am Soc Nephrol. 2026;37:1954-1968.
    >> Share

  9. CATANESE B, Miller C, Wolf M, Edmonston D, et al
    Cardiovascular Outcomes among New Users of GLP-1 Receptor Agonists Compared with DPP-4 Inhibitors and Sulfonylureas in Kidney Failure.
    J Am Soc Nephrol. 2026;37:1992-2003.
    >> Share

    August 2026
  10. MOORE E, Haak J, Fernadez P, Beardsley S, et al
    Dialysis Access without Guesswork: A Digital Navigation Framework for Improved Access Technique.
    J Am Soc Nephrol. 2026 Aug 31. doi: 10.1681/ASN.0000001267.
    >> Share

  11. MCCOY I, Liu KD, Siew E, Tuot DS, et al
    Dialysis Discontinuation Rates at Low Levels of Kidney Function in Patients with Acute Kidney Injury on Intermittent Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 25. doi: 10.1681/ASN.0000001245.
    >> Share

  12. ZHOU Z, Yang B
    Joint Interpretation of Long-Chain and Very Long-Chain Sphingolipid Associations with Mortality in Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 21. doi: 10.1681/ASN.0000001211.
    >> Share

  13. LIDGARD B, Jensen PN, Sitlani CM, Lemaitre RN, et al
    Authors' Reply: Joint Interpretation of Long-Chain and Very Long-Chain Sphingolipid Associations with Mortality in Hemodialysis.
    J Am Soc Nephrol. 2026 Aug 21. doi: 10.1681/ASN.0000001212.
    >> Share

  14. CHEN J, Jiang Y
    Sphingolipids and Death in Hemodialysis: A Data Inconsistency and Unaddressed Competing Risk.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001226.
    >> Share

  15. GARG AX, Al-Jaishi AA, Conklin AI, McKenzie SQ, et al
    Alterations to the Consent Process in Five Pragmatic Randomized Trials of Routine Hemodialysis Care.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001251.
    >> Share

  16. LIDGARD B, Jensen PN, Zelnick LR
    Authors' Reply: Sphingolipids and Death in Hemodialysis: A Data Inconsistency and Unaddressed Competing Risk.
    J Am Soc Nephrol. 2026 Aug 20. doi: 10.1681/ASN.0000001227.
    >> Share

  17. STRIPPOLI GFM, Tripepi G, Canaud B, Stuard S, et al
    Hemodiafiltration versus High-flux Hemodialysis and Risk of Mortality: A Multinational Target Trial Emulation?.
    J Am Soc Nephrol. 2026 Aug 13. doi: 10.1681/ASN.0000001225.
    >> Share

  18. ADLER JT, Kuk AE, Drewry KM, Nguyen KH, et al
    Medicare Advantage and Access to Living Donor Kidney Transplantation among Older Patients Receiving Dialysis.
    J Am Soc Nephrol. 2026 Aug 5. doi: 10.1681/ASN.0000001209.
    >> Share

    July 2026
  19. SHANG Y, Jin J, He Q
    Dialysis Day beta -Blocker Exposure in Hemodialysis : What Exactly Was Emulated?
    J Am Soc Nephrol. 2026 Jul 28. doi: 10.1681/ASN.0000001179.
    >> Share

  20. ETEMADI A, Winkelmayer WC, Montez-Rath ME, Chang TI, et al
    Authors' Reply: Dialysis Day beta-Blocker Exposure in Hemodialysis: What Exactly Was Emulated?
    J Am Soc Nephrol. 2026 Jul 28. doi: 10.1681/ASN.0000001180.
    >> Share

  21. HSU CM, Miskulin DC
    Influenza Vaccination in Dialysis: New Technologies for a Vulnerable Population.
    J Am Soc Nephrol. 2026 Jul 24. doi: 10.1681/ASN.0000001185.
    >> Share

  22. STANAWAY IB, Costa IPD, Davies SJ, Perl J, et al
    Correction to: Genetic Variation and Ultrafiltration with Peritoneal Dialysis: A Genome-Wide Association Study.
    J Am Soc Nephrol. 2026 Jul 22. doi: 10.1681/ASN.0000001222.
    >> Share

    June 2026
  23. QUINN RR, Oliver MJ, Wald R, Hiremath S, et al
    Comparing Catheters to Fistulas in Older Patients Starting Hemodialysis (ACCESS HD).
    J Am Soc Nephrol. 2026 Jun 22. doi: 10.1681/ASN.0000001160.
    >> Share

  24. WILK AS, Drewry KM
    Fiscal Impact of Public Policy on Costs of the Medicare ESRD Program.
    J Am Soc Nephrol. 2026 Jun 9. doi: 10.1681/ASN.0000001156.
    >> Share

  25. WILKIE M, Heimburger O, de Leon C, Carlsson O, et al
    Ultrafiltration and Sodium Removal in Steady Concentration Peritoneal Dialysis: A Prospective, Multicenter, Randomized, Crossover Study.
    J Am Soc Nephrol. 2026 Jun 4. doi: 10.1681/ASN.0000001152.
    >> Share

  26. WONG SPY, Schell JO, Bursic AE, Butler CR, et al
    ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.
    J Am Soc Nephrol. 2026;37:1291-1303.
    >> Share

  27. WEISS JW, Hall R, Saeed F, Callahan MB, et al
    Executive Summary of ASN Kidney Health Guidance on Conservative Management in People with Kidney Failure.
    J Am Soc Nephrol. 2026;37:1287-1290.
    >> Share

    May 2026
  28. SCHELL JO, Schwarze ML, Arnold RM, Moss AH, et al
    Applying a Better Conversations Framework to Dialysis Decision-Making for Patients with Advanced CKD.
    J Am Soc Nephrol. 2026 May 29. doi: 10.1681/ASN.0000001163.
    >> Share

  29. ETEMADI A, Liu S, Winkelmayer WC, Montez-Rath ME, et al
    Nondialyzable versus Dialyzable Beta-Blockers in Hemodialysis: A Target Trial Emulation Study.
    J Am Soc Nephrol. 2026 May 20. doi: 10.1681/ASN.0000001147.
    >> Share

  30. BIEBER B, Aragon M, D'Alessandri-Silva C, Repeck K, et al
    Risk of Vascular Access-Related Infections in Home Versus In-Center Hemodialysis.
    J Am Soc Nephrol. 2026 May 5. doi: 10.1681/ASN.0000001140.
    >> Share

    April 2026
  31. SAUM KL, Pennathur S
    Sphingolipids and Mortality in Hemodialysis: Innocent Bystanders or Causal Culprits?
    J Am Soc Nephrol. 2026 Apr 27. doi: 10.1681/ASN.0000001110.
    >> Share

  32. BRIGGS JP, Hostetter TH
    For-Profit Dialysis and Academic Neglect Are Undermining Dialysis Research in the United States.
    J Am Soc Nephrol. 2026 Apr 20. doi: 10.1681/ASN.0000001128.
    >> Share

  33. DAVIS JW, Layton JB, Sahrmann JM, Nickel KB, et al
    Comparative Effectiveness of Different Influenza Vaccine Formulations among Patients Undergoing Maintenance Hemodialysis.
    J Am Soc Nephrol. 2026 Apr 13. doi: 10.1681/ASN.0000001099.
    >> Share

  34. SHAH AD, Liao Y, Lee Y, Mor V, et al
    Untangling Dialysis Received in a Nursing Home from Home Hemodialysis in the Community.
    J Am Soc Nephrol. 2026 Apr 2. doi: 10.1681/ASN.0000001109.
    >> Share

    March 2026
  35. CHERTOW GM, Agarwal R, Burke SK, Luo W, et al
    Comparing Vadadustat and Darbepoetin in Maintenance Dialysis with CKD-Related Anemia: A Win Statistics Analysis.
    J Am Soc Nephrol. 2026 Mar 17. doi: 10.1681/ASN.0000001090.
    >> Share

  36. SHUKLA AM, Scheiffele G, Huang W, Campbell-Montalvo R, et al
    Correction to: Race- and Ethnicity-Related Disparities in Predialysis Nephrology Care, Kidney Disease Education, and Home Dialysis Utilization.
    J Am Soc Nephrol. 2026 Mar 5. doi: 10.1681/ASN.0000001075.
    >> Share

    February 2026
  37. LIDGARD B, Bansal N, Lemaitre R
    Authors' Reply: Dialysis Dose and Flux as Potential Effect Modifiers of Sphingolipid-Mortality Associations.
    J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001034.
    >> Share

  38. ZHAO Q, Yang Y, Liu X, Chen J, et al
    Dialysis Dose and Flux as Potential Effect Modifiers of Sphingolipid-Mortality Associations.
    J Am Soc Nephrol. 2026 Feb 25. doi: 10.1681/ASN.0000001033.
    >> Share

  39. LEAGUE R, McDevitt RC
    The Fiscal Impact of the Medicare Secondary Payer Act for End-Stage Renal Disease.
    J Am Soc Nephrol. 2026 Feb 3. doi: 10.1681/ASN.0000001028.
    >> Share

    December 2025
  40. JAIN N, Dhamelia P, Arthur JM
    Fungal DNA in Circulation: A Sleuth's Clue to Predict Cardiovascular Risk for Hemodialysis Patients.
    J Am Soc Nephrol. 2025 Dec 29. doi: 10.1681/ASN.0000000993.
    >> Share

  41. KNAPP CD, Li S, Kou C, Wetmore JB, et al
    Peritoneal Dialysis Initiation Patterns by Health Service Area during an Era of Expansion.
    J Am Soc Nephrol. 2025 Dec 26. doi: 10.1681/ASN.0000000989.
    >> Share

  42. WALTHER CP, Nair AP
    Management of Dialysis for Patients Receiving Mechanical Circulatory Support.
    J Am Soc Nephrol. 2025 Dec 24. doi: 10.1681/ASN.0000001013.
    >> Share

  43. LIDGARD B, Hoofnagle AN, Zelnick LR, de Boer IH, et al
    Association of Sphingolipids with All-Cause and Cardiovascular Death in Patients with Kidney Failure Treated with Maintenance Hemodialysis.
    J Am Soc Nephrol. 2025 Dec 19. doi: 10.1681/ASN.0000000982.
    >> Share

  44. KUCIRKA LM, Boggess KA, Wood ME, Quist-Nelson J, et al
    Severe Maternal Morbidity and Long-Term Kidney Outcomes among Pregnant Women Receiving Maintenance Dialysis.
    J Am Soc Nephrol. 2025 Dec 1. doi: 10.1681/ASN.0000000949.
    >> Share

    October 2025
  45. MAYNE KJ, Herrington WG
    "Hi"s and "Lo"s of Targeting Serum Phosphate Levels in Hemodialysis.
    J Am Soc Nephrol. 2025 Oct 30. doi: 10.1681/ASN.0000000903.
    >> Share

  46. KAPLAN JM, Niu J, Ho V, Winkelmayer WC, et al
    Correction to: A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis.
    J Am Soc Nephrol. 2025 Oct 15. doi: 10.1681/ASN.0000000918.
    >> Share

    August 2025
  47. ALVARADO F, Hall RK
    Peer Support for Hemodialysis Patients: Moving from Effectiveness to Implementation.
    J Am Soc Nephrol. 2025 Aug 25. doi: 10.1681/ASN.0000000839.
    >> Share

  48. SUMIDA K, Mallisetty Y, Chiu CY, Han Z, et al
    Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis.
    J Am Soc Nephrol. 2025 Aug 11. doi: 10.1681/ASN.0000000829.
    >> Share

    July 2025
  49. CHENG FWT, Xu W, Tang SCW, Wan EYF, et al
    Authors' Reply: Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000800.
    >> Share

  50. LIN J, Luo L
    Statins' Efficacy Controversy in Kidney Failure: Reassessing Safety and Dialysis Stratification Need.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000798.
    >> Share

  51. CHRISTOU CD, Jaradat F, Olsburgh J, Sacks S, et al
    Rationale for Targeting Complement to Mitigate Renal Transplant Ischemia-Reperfusion Injury.
    J Am Soc Nephrol. 2025 Jul 22. doi: 10.1681/ASN.0000000826.
    >> Share

  52. STANAWAY IB, Costa IPD, Davies SJ, Perl J, et al
    Genetic Variation and Ultrafiltration with Peritoneal Dialysis: A Genome-Wide Association Study.
    J Am Soc Nephrol. 2025 Jul 16. doi: 10.1681/ASN.0000000803.
    >> Share

  53. KLEIN KR, Flythe JE
    Time to Plan for Continuous Glucose Monitoring in Dialysis-Dependent Kidney Failure.
    J Am Soc Nephrol. 2025 Jul 10. doi: 10.1681/ASN.0000000794.
    >> Share

  54. EDMONSTON D, Isakova T, Dember LM, Waymyers S, et al
    Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Jul 10. doi: 10.1681/ASN.0000000765.
    >> Share

    June 2025
  55. GOLESTANEH L, Melamed ML, Cavanaugh KL
    Authors' Reply: Peer Mentorship's Paradox in Dialysis: Neutral Overall but Lifesaving for Black Patients: Toward Equity-Driven Trial Designs.
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000782.
    >> Share

  56. ZHANG Y, Wang K, Yang L
    Peer Mentorship's Paradox in Dialysis: Neutral Overall but Lifesaving for Black Patients: Toward Equity-Driven Trial Designs.
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000781.
    >> Share

  57. BLANKESTIJN PJ
    Do Medium Cut-Off Dialyzers Offer Any Clinical Benefit or Should We Focus on Hemodiafiltration?
    J Am Soc Nephrol. 2025 Jun 27. doi: 10.1681/ASN.0000000777.
    >> Share

  58. DAUGIRDAS JT
    Ancillary Holographic No-Touch Control of Hemodialysis Machine Settings.
    J Am Soc Nephrol. 2025 Jun 26. doi: 10.1681/ASN.0000000807.
    >> Share

  59. SHI KX, Tuot DS
    Telemedicine for Hemodialysis Care Delivery: Value Added?
    J Am Soc Nephrol. 2025 Jun 5. doi: 10.1681/ASN.0000000755.
    >> Share

    April 2025
  60. GOLESTANEH L, Kim RS, Roach C, Norris KC, et al
    Effect of Peer Mentorship on Hospitalizations among Patients Receiving Maintenance Hemodialysis: A Pragmatic Randomized Controlled Trial.
    J Am Soc Nephrol. 2025 Apr 15. doi: 10.1681/ASN.0000000709.
    >> Share

  61. LAZARUS B, Davies SJ, Polkinghorne KR
    Volume Assessment in Patients Undergoing Long-Term Dialysis.
    J Am Soc Nephrol. 2025 Apr 7. doi: 10.1681/ASN.0000000724.
    >> Share

  62. BABROUDI S, Tighiouart H, Weiner DE, Neyra JA, et al
    Association of Social Risk Factors with Kidney Function Recovery among Patients with Acute Kidney Injury Receiving Outpatient Dialysis.
    J Am Soc Nephrol. 2025 Apr 2. doi: 10.1681/ASN.0000000692.
    >> Share

  63. MEYER TW
    Increasing the Removal of Large Solutes by Kidney Replacement Therapy.
    J Am Soc Nephrol. 2025;36:734-743.
    >> Share

    March 2025
  64. DE BOER IH, Anderson LD, Ashford NK, Ayers E, et al
    Glycemia Assessed by Continuous Glucose Monitoring among People Treated with Maintenance Dialysis.
    J Am Soc Nephrol. 2025 Mar 21. doi: 10.1681/ASN.0000000693.
    >> Share

  65. KOJIMA S, Usui N, Uehata A, Inatsu A, et al
    Acute Effect of Moderate-Intensity Interval Intradialytic Exercise on Cerebral Oxygenation in Hemodialysis Patients: A Randomized Crossover Trial.
    J Am Soc Nephrol. 2025 Mar 12. doi: 10.1681/ASN.0000000672.
    >> Share

  66. LIM JH, Seo YJ, Jeon Y, Jeon YH, et al
    Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Incident Hemodialysis Patients.
    J Am Soc Nephrol. 2025 Mar 4. doi: 10.1681/ASN.0000000655.
    >> Share

    February 2025
  67. VIJAYAN A, Heung M, Awdishu L, Babroudi S, et al
    ASN Kidney Health Guidance on the Outpatient Management of Patients with Dialysis-Requiring Acute Kidney Injury.
    J Am Soc Nephrol. 2025 Feb 27. doi: 10.1681/ASN.0000000646.
    >> Share

  68. ANDREWS TD, Day GS, Irani SR, Kanekiyo T, et al
    Uremic Toxins, Chronic Kidney Disease, and Cognitive Dysfunction.
    J Am Soc Nephrol. 2025 Feb 26. doi: 10.1681/ASN.0000000675.
    >> Share

  69. LAZARUS B, Lok CE, Moist L, Polkinghorne KR, et al
    Strategies to Prevent Hemodialysis Catheter Dysfunction.
    J Am Soc Nephrol. 2025 Feb 20. doi: 10.1681/ASN.0000000666.
    >> Share

  70. WATNICK S, McNamara E, Weiner DE
    Better Dialysis Care in the United States Requires New Payment Policy: No Patient Left Behind.
    J Am Soc Nephrol. 2025 Feb 14. doi: 10.1681/ASN.0000000663.
    >> Share

    January 2025
  71. SUN Y, Huang Q, Sun J, Zhou H, et al
    MAIT Cell-Mediated Immune Mechanisms of Dialysis-Induced Peritoneal Fibrosis and Therapeutic Targeting.
    J Am Soc Nephrol. 2025 Jan 28. doi: 10.1681/ASN.0000000627.
    >> Share

  72. NIU J, Rosales O, Oluyomi A, Lew SQ, et al
    Utilization of Telemedicine for Patients Receiving In-center Hemodialysis in the United States.
    J Am Soc Nephrol. 2025 Jan 16. doi: 10.1681/ASN.0000000619.
    >> Share

    December 2024
  73. BONNET C, Torreggiani M, Bianco L, Amiard F, et al
    Autopsy of a Hemodialysis Machine: Potential for Recycling at the End of the Life Cycle.
    J Am Soc Nephrol. 2024 Dec 13. doi: 10.1681/ASN.0000000584.
    >> Share

    November 2024
  74. HAREL Z, Smyth B, Badve SV, Blum D, et al
    Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.
    J Am Soc Nephrol. 2024 Nov 4. doi: 10.1681/ASN.0000000000000495.
    >> Share

    October 2024
  75. KORTL T, Hankowitz N, Stengel L, Pfeuffer O, et al
    In Vitro Simulation of Hemodialysis Reveals Hemodialysis-Associated Pro-Arrhythmic Effects in a Human Cardiomyocyte Model.
    J Am Soc Nephrol. 2024 Oct 25. doi: 10.1681/ASN.0000000563.
    >> Share

    September 2024
  76. SHUKLA AM, Scheiffele G, Huang W, Campbell-Montalvo R, et al
    Race-and Ethnicity-Related Disparities in Predialysis Nephrology Care, Kidney Disease Education, and Home Dialysis Utilization.
    J Am Soc Nephrol. 2024 Sep 4. doi: 10.1681/ASN.0000000000000489.
    >> Share

  77. KIMMEL PL, Fwu CW, Nolin TD, Schulman IH, et al
    Opioid Prescriptions for US Patients Undergoing Long-Term Dialysis or with Kidney Transplant from 2011 to 2020.
    J Am Soc Nephrol. 2024 Sep 3. doi: 10.1681/ASN.0000000000000478.
    >> Share

    August 2024
  78. DEVUYST O
    Aquaporin-1 and Osmosis: From Physiology to Precision in Peritoneal Dialysis.
    J Am Soc Nephrol. 2024 Aug 26. doi: 10.1681/ASN.0000000000000496.
    >> Share

  79. ROBERTS GV, Jefferson NM, Picillo R, Torreggiani M, et al
    Patient, Nurse, and Physician Perspectives on Personalized, Incremental Hemodialysis.
    J Am Soc Nephrol. 2024 Aug 12. doi: 10.1681/ASN.0000000000000467.
    >> Share

  80. REDDY YNV, O'Hare AM, Edwards D, Hall R, et al
    Defining, Understanding, and Addressing Postdialysis Fatigue: Takeaways from a Scientific Workshop Hosted by the National Institutes of Health.
    J Am Soc Nephrol. 2024;35:1130-1133.
    >> Share

  81. HIMMELFARB J, Ratner BD
    An Innovation Ecosystem: The Center for Dialysis Innovation (CDI).
    J Am Soc Nephrol. 2024;35:1119-1122.
    >> Share

    July 2024
  82. PAJEWSKI NM, Beddhu S, Bress AP, Chang TI, et al
    The Legacy Effect of Intensive versus Standard Blood Pressure Control on the Incidence of Dialysis or Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 30. doi: 10.1681/ASN.0000000000000459.
    >> Share

  83. GUPTA A, Holloway P, Young K, Villwock J, et al
    Changes in Olfactory and Cognitive Function after Kidney Transplantation.
    J Am Soc Nephrol. 2024 Jul 9. doi: 10.1681/ASN.0000000000000456.
    >> Share

  84. PINTER J, Smyth B, Jardine M
    Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All.
    J Am Soc Nephrol. 2024;35:977.
    >> Share

  85. HECKING M, Karaboyas A, Krenn S, Mussnig S, et al
    Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?
    J Am Soc Nephrol. 2024;35:972-973.
    >> Share

  86. FERNANDES G, Pochet JM, Labriola L
    Dialysate Sodium and Mortality: One Size Does Not Fit All.
    J Am Soc Nephrol. 2024;35:976.
    >> Share

  87. LI Y, Menon G, Long JJ, Chen Y, et al
    Neighborhood Racial and Ethnic Segregation and the Risk of Dementia in Older Adults Living with Kidney Failure.
    J Am Soc Nephrol. 2024;35:936-948.
    >> Share

  88. PATZER RE
    Bridging Racial Disparities in Access to Kidney Transplantation in the United States: Glass Part-Empty or Part-Full?
    J Am Soc Nephrol. 2024;35:959-961.
    >> Share

    June 2024
  89. PINTER J, Jardine M, Canaud B, Genser B, et al
    Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?
    J Am Soc Nephrol. 2024 Jun 6. doi: 10.1681/ASN.0000000000000376.
    >> Share

  90. DEGRAAUW J, Wong SPY
    Engaging Patients in Decision Making about Treatment of Kidney Failure: The Art and Science of Communication.
    J Am Soc Nephrol. 2024;35:673-675.
    >> Share

    May 2024
  91. ISMAIL S, Funk MJ, Flythe JE
    Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.
    J Am Soc Nephrol. 2024 May 20. doi: 10.1681/ASN.0000000000000386.
    >> Share

  92. HUNG KC, Chao CT
    Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.
    J Am Soc Nephrol. 2024 May 20. doi: 10.1681/ASN.0000000000000385.
    >> Share

  93. MCINTYRE CW
    Update on Hemodialysis-Induced Multiorgan Ischemia: Brains and Beyond.
    J Am Soc Nephrol. 2024;35:653-664.
    >> Share

    April 2024
  94. MCALISTER S, Talbot B, Knight J, Blair S, et al
    The Carbon Footprint of Peritoneal Dialysis in Australia.
    J Am Soc Nephrol. 2024 Apr 26. doi: 10.1681/ASN.0000000000000361.
    >> Share

  95. BABROUDI S, Weiner DE, Neyra JA, Drew DA, et al
    Acute Kidney Injury Receiving Dialysis and Dialysis Care following Hospital Discharge.
    J Am Soc Nephrol. 2024 Apr 23. doi: 10.1681/ASN.0000000000000383.
    >> Share

  96. STEINER RW
    Equity in Preemptive Kidney Transplantation: The Case for Caution.
    J Am Soc Nephrol. 2024 Apr 8. doi: 10.1681/ASN.0000000000000347.
    >> Share

    March 2024
  97. KU E, McCulloch CE, Copeland TP, Johansen KL, et al
    Authors' Reply: Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty.
    J Am Soc Nephrol. 2024;35:382-383.
    >> Share

  98. SAHUTOGLU T
    Prioritizing Skills for Optimal Peritoneal Dialysis Care: A Focus Beyond Specialty.
    J Am Soc Nephrol. 2024;35:381.
    >> Share

    February 2024
  99. ISMAIL S, Funk MJ, Flythe JE
    Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.
    J Am Soc Nephrol. 2024 Feb 27. doi: 10.1681/ASN.0000000000000336.
    >> Share

    January 2024
  100. ADLER JT, Kuk AE, Cron DC, Parast L, et al
    Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.
    J Am Soc Nephrol. 2024 Jan 15. doi: 10.1681/ASN.0000000000000298.
    >> Share

    December 2023
  101. HUSAIN SA
    Recentering Accountability for Disparities in Kidney Transplant Access.
    J Am Soc Nephrol. 2023 Dec 12. doi: 10.1681/ASN.0000000000000290.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016